Emergent BioSolutions Inc. (0IGA.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 661.26M |
| Enterprise Value | 1.05B |
| P/E Ratio | -46.18 |
| PEG Ratio | 0.39 |
| Price/Sales Ratio | 0.6 |
| Price/Book Ratio | 0.78 |
| Enterprise/Revenue | 1.21 |
| Enterprise/EBITDA | 5.3 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.01 |
| Operating Margin | 0.11 |
AD
Management Effectiveness
| Return On Assets | -0.01 |
| Return On Equity | -0.02 |
Income Statement
| Revenue | 742.9M |
| Revenue/Share | 13.04 |
| Gross Profit | 361.2M |
| EBITDA | 217.9M |
| Net Income | 52.6M |
| Diluted EPS | 0.93 |
Balance Sheet
| Total Cash | 161.5M |
| Total Cash/Share | 3.09 |
| Total Debt | 635M |
| Total Debt/Equity | 1.1 |
| Current Ratio | 4.29 |
| Book Value Per Share | 10.08 |
Price History
| 52-Week Change | 26.09 |
| 52-Week High | 13.42 |
| 52-Week Low | 1.48 |
| Moving Average 50 Days | 2.24 |
| Moving Average 200 Days | 4.13 |
Statistics
| Average Volume | 19,429 |
| Shares Outstanding | 52.88M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
